
|Articles|December 15, 2002
EMGT finds lower IOP delays progression
Malm?weden-The initial results of the Early Manifest Glaucoma Trial (EMGT), a National Eye Institute-sponsored study conducted in Sweden, suggest that IOP-lowering treatment significantly delays progression of open-angle glaucoma in patients with elevated and normal IOP.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
AAO 2025: Which lens to consider in patients with pseudoexfoliation
3
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
4
News from Orlando: AAO 2025 highlights research across all areas of eyecare
5